FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of biotechnology. Characterised is application of therapeutically efficient quantity of peptide GGF2, which contains domain, similar to epidermal growth factor (EGF-like), in treatment or prevention of heart failure in mammal by injection of said peptide every 48 hours in dose, which constitutes from approximately 0.001 mg/kg to approximately 10 mg/kg.
EFFECT: invention improves therapeutic effect with introduction of neuroregulin with minimisation of any potential side effects.
14 cl, 15 dwg, 11 tbl
